LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
70.60
-0.40 (-0.56%)
Feb 27, 2026, 4:00 PM EST - Market closed
LivaNova Market Cap
LivaNova has a market cap or net worth of $3.86 billion as of February 27, 2026. Its market cap has increased by 49.23% in one year.
Market Cap
3.86B
Enterprise Value
3.66B
1-Year Change
49.23%
Ranking
Category
Stock Price
$70.60
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has increased from $3.42B to $3.86B, an increase of 13.05%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.86B | 14.92% |
| Dec 31, 2025 | 3.36B | 33.61% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Rad Laboratories | 7.40B |
| Bio-Rad Laboratories | 7.40B |
| Glaukos | 6.94B |
| Bruker | 6.11B |
| TransMedics Group | 4.85B |
| iRhythm Holdings | 4.39B |
| Integer Holdings | 2.98B |
| Haemonetics | 2.93B |